Picture of Genus logo

GNS Genus News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

Director/PDMR Shareholding

RNS Number : 0482Z

Genus PLC

01 April 2026

 

1 April 2026

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that further to the share awards granted to Jim Low, a member of the Genus Executive Leadership Team, on 11 September 2024 under a Restricted Stock Award (RSA) over ordinary shares in Genus, 7,307 share awards granted pursuant to the above RSA vested on 31 March 2026, as listed in table A below, and 7,307 shares were released to Jim Low.   In order to offset income tax and social security liabilities due on the vesting of those share awards, Jim Low sold 2,756 ordinary shares on 31 March 2026 and retained the balance of 4,551 ordinary shares, as listed in table B below.

 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the PDMR transactions described above.

 

For further information please contact:

 

Genus:

Lucie Grant, Group General Counsel and Company Secretary          Tel: +44 (0)1256 347100

 

Table A - Vesting of buy-out awards on 31 March 2026

1.Details of the person discharging managerial responsibilities / person closely associated
a.NameJim Low
2.Reason for the notification
a.Position/statusChief Operating Officer, ABS
b.Initial notification
/Amendment
Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.NameGenus plc
b.LEI54930022EOITNKSIGH56
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB0002074580
b.Nature of the transactionVesting of share awards and release of shares on 31 March 2026 under a Restricted Stock Award over ordinary shares in Genus.
c.Price(s) and volume(s)
Price(s)Volume(s)
0p7,307
d.Aggregated information
· Aggregated volume
· Price
Average price(s)Total volume(s)
0p7,307
e.Date of the transaction2026-03-31
f.Place of the transactionOutside a trading venue.
  Table B - Sale of sufficient ordinary shares on 31 March 2026 to cover tax and social security liabilities
1.Details of the person discharging managerial responsibilities / person closely associated
a.NameJim Low
2.Reason for the notification
a.Position/statusChief Operating Officer, ABS
b.Initial notification
/Amendment
Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.NameGenus plc
b.LEI54930022EOITNKSIGH56
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB0002074580
b.Nature of the transactionSale of shares arising from the vesting of share awards under Restricted Stock Award to offset income tax and social security liabilities due on the vesting.
c.Price(s) and volume(s)
Price(s)Volume(s)
2,405p2,756
d.Aggregated information
· Aggregated volume
· Price
Average price(s)Total volume(s)
2,405p2,756
e.Date of the transaction2026-03-31
f.Place of the transactionLondon Stock Exchange.
    This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     DSHVFLBBQZLXBBK

Recent news on Genus

See all news